A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

NCT01178073 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

610

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension, Pulmonary

Interventions

DRUG: ambrisentan
DRUG: tadalafil

Sponsor

GlaxoSmithKline

Collaborators

[object Object]